Analytical Data
-
基因名
SLC25A30
- Application
-
别名
Solute carrier family 25 member 30
-
种属
Human
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q5SVS4
-
表达区间
1-291aa
-
分子量
48.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The SLC25A30 gene encodes a mitochondrial carrier protein that plays a crucial role in the transport of metabolites across the inner mitochondrial membrane. Recent studies have highlighted its involvement in mitochondrial function, cellular metabolism, and energy production. Dysregulation or mutations in SLC25A30 have been linked to various metabolic disorders and mitochondrial diseases, underscoring the importance of understanding its functional mechanisms. Research into the recombinant expression of SLC25A30 is vital for elucidating its structural characteristics and transport mechanisms, which are essential for elucidating its biological roles. By producing recombinant SLC25A30 protein in a controlled laboratory setting, scientists aim to investigate its substrate specificity, interaction with other mitochondrial proteins, and participation in metabolic pathways. This research can potentially lead to novel therapeutic strategies for conditions associated with mitochondrial dysfunction and provide insights into the broader field of mitochondrial biology. Furthermore, the ability to study SLC25A30 in vitro allows for the development of assays that can be used in drug screening and the exploration of its role as a potential drug target. Overall, the study of recombinant SLC25A30 protein is a promising avenue for advancing our understanding of mitochondrial dynamics and their implications for human health and disease.
